PET Imaging Agent May Allow Early Measurement of Efficacy of Breast Cancer Therapy
February 11, 2019
February 11, 2019
RESTON, Virginia, Feb. 11 -- The Society of Nuclear Medicine and Molecular Imaging issued the following news release:
Physicians may soon have a new way to measure the efficacy or failure of hormone therapy for breast cancer patients, according to new research published in the February issue of The Journal of Nuclear Medicine. Researchers report that positron emission tomography (PET) imaging with 18F-fluorofuranylnorprogesterone (18F-FFNP) has been found to successfully measure cha . . .
Physicians may soon have a new way to measure the efficacy or failure of hormone therapy for breast cancer patients, according to new research published in the February issue of The Journal of Nuclear Medicine. Researchers report that positron emission tomography (PET) imaging with 18F-fluorofuranylnorprogesterone (18F-FFNP) has been found to successfully measure cha . . .